LCKYF yields 984.74% · JNJ yields 2.13%● Live data
📍 LCKYF pulled ahead of the other in Year 1
Combined, LCKYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LCKYF + JNJ for your $10,000?
Golden Sky Minerals Corp. operates as a mineral exploration company in Canada. The company engages in acquisition, development, exploration, and evaluation of mineral properties. It primarily explores for gold deposits. The company holds 100% interest in the Lucky Strike property located in Yukon, Canada; the BRC property located in Yukon, Canada; and the Gold Source property located in southwest of Dawson, Yukon. It also holds 100% interest in the Hot Spot Property located in south of Dawson, Yukon; the King's Ransom Property; the Bull's Eye Property located in south of Dawson, Yukon; the Rayfield Property located in British Columbia, Canada; and the Eagle Mountain gold property that covers an area of approximately 10,000 hectares located in the Cassiar District of British Columbia. The company was formerly known as Luckystrike Resources Ltd. and changed its name to Golden Sky Minerals Corp. in February 2020. Golden Sky Minerals Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.
Full LCKYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.